These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 10226202

  • 1. Repeated office blood pressure controls reduce the prevalence of white-coat hypertension and detect a group of white-coat normotensive patients.
    Fogari R, Corradi L, Zoppi A, Lusardi P, Poletti L.
    Blood Press Monit; 1996 Feb; 1(1):51-54. PubMed ID: 10226202
    [Abstract] [Full Text] [Related]

  • 2. Comparison between continuous ambulatory arterial blood pressure monitoring and standard blood pressure measurements among patients of younger and older age group.
    Babić BK, Bagatin J, Kokić S, Ostojić SB, Carević V, Berović N.
    Coll Antropol; 2009 Mar; 33(1):65-70. PubMed ID: 19408605
    [Abstract] [Full Text] [Related]

  • 3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P, Vasconcelos N, Santos I, Almeida L, Nazaré J, Carmona J.
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. White-coat hypertension and sex.
    James GD, Marion R, Pickering TG.
    Blood Press Monit; 1998 Oct; 3(5):281-287. PubMed ID: 10212367
    [Abstract] [Full Text] [Related]

  • 6. Office hypertension: abnormal blood pressure regulation and increased sympathetic activity compared with normotension.
    Middeke M, Lemmer B.
    Blood Press Monit; 1996 Oct; 1(5):403-407. PubMed ID: 10226267
    [Abstract] [Full Text] [Related]

  • 7. [Is prevalence of the "white coat effect" correlated with a high risk of late diabetic complications in type 2 diabetic patients?].
    Mozdzan M, Ruxer J, Barański M, Roszczyk N, Markuszewski L.
    Ann Acad Med Stetin; 2008 Oct; 54(1):65-9; discussion 69. PubMed ID: 19127812
    [Abstract] [Full Text] [Related]

  • 8. 'White coat' hypertension in children.
    Hornsby JL, Mongan PF, Taylor AT, Treiber FA.
    J Fam Pract; 1991 Dec; 33(6):617-23. PubMed ID: 1744607
    [Abstract] [Full Text] [Related]

  • 9. Assessment of the white-coat effect among hypertensive patients presumed to be at goal.
    Bookstaver DA, Hatzigeorgiou C.
    Ann Pharmacother; 2011 Jul; 45(7-8):910-5. PubMed ID: 21750311
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ["White-coat hypertension": variation of normality or of hypertension?].
    Carmona J, Amado P, Vasconcelos N, Santos I, Pinto C, Forte G, Arsénio A, Nazaré J.
    Rev Port Cardiol; 1998 Jun; 17(6):505-12. PubMed ID: 9677828
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.
    Kato T, Horio T, Tomiyama M, Kamide K, Nakamura S, Yoshihara F, Nakata H, Nakahama H, Kawano Y.
    Nephrol Dial Transplant; 2007 Mar; 22(3):911-6. PubMed ID: 17142262
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.